Portfolio company short bio
AROMICS is a biotechnology company focused on development of novel therapies for the treatment of cancer.
Portfolio Company Info
AROMICS is a development-stage biotechnology company focused on development of novel small molecules targeting RNA for treatment of cancer. NAX035 is the first lead advancing into clinics. As first indication, we have selected malignant mesothelioma, a rare and incurable cancer related to asbestos exposure.
Founder/CEO name: Carmen Plasencia (LinkedIn)
Location: Barcelona, Spain
Sector: Health - Biotechnology, medical, health
Total amount raised (mln EUR): 4.5
Employees range: 2-10
Request a contact